Neutrophil Extracellular Vesicles: A Delicate Balance between Pro-Inflammatory Responses and Anti-Inflammatory Therapies

Cells. 2022 Oct 21;11(20):3318. doi: 10.3390/cells11203318.

Abstract

Extracellular vesicles (EVs) are released in the extracellular environment during cell activation or apoptosis. Working as signal transducers, EVs are important mediators of intercellular communication through the convoying of proteins, nucleic acids, lipids, and metabolites. Neutrophil extracellular vesicles (nEVs) contain molecules acting as key modulators of inflammation and immune responses. Due to their potential as therapeutic tools, studies about nEVs have been increasing in recent years. However, our knowledge about nEVs is still in its infancy. In this review, we summarize the current understanding of the role of nEVs in the framework of neutrophil inflammation functions and disease development. The therapeutic potential of nEVs as clinical treatment strategies is deeply discussed. Moreover, the promising research landscape of nEVs in the near future is also examined.

Keywords: extracellular vesicles; inflammation; neutrophils; therapy.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents / metabolism
  • Extracellular Vesicles* / metabolism
  • Humans
  • Inflammation / metabolism
  • Lipids
  • Neutrophils / metabolism
  • Nucleic Acids* / metabolism

Substances

  • Anti-Inflammatory Agents
  • Nucleic Acids
  • Lipids

Grants and funding

This work was supported by the University of Luxembourg and the Fonds National de la Recherche through the PRIDE/11012546/NEXTIMMUNE FNR-PRIDE Doctoral Training Unit program NEXTIMMUNE (PRIDE/11012546/NEXTIMMUNE).